Co-Authors
This is a "connection" page, showing publications co-authored by DAVID SANGHYUN HONG and YASUHIRO OKI.
Connection Strength
0.068
-
Safety and Efficacy of Vorinostat Plus Sirolimus or Everolimus in Patients with Relapsed Refractory Hodgkin Lymphoma. Clin Cancer Res. 2020 11 01; 26(21):5579-5587.
Score: 0.047
-
Decitabine effect on tumor global DNA methylation and other parameters in a phase I trial in refractory solid tumors and lymphomas. Clin Cancer Res. 2009 Jun 01; 15(11):3881-8.
Score: 0.021